← All indications
Depressive Disorder, Treatment-Resistant
Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
Drugs by status
Phase 4 trials (20)
Phase 3 trials (15)
Phase 2 trials (24)
Phase 1 trials (7)
Organizations
Organization Involved with Phase 4 Indications (28)
- Bristol-Myers Squibb
- Teva
- National Institute of Mental Health (NIMH)
- Cancer Research Network
- University of London
- Harvard University
- Essentia Health
- Newcastle University
- University of Saskatchewan
- University of Bath
- Columbia University
- Stony Brook University
- Tel Aviv University
- University of California, Los Angeles
- University of Utah
- Vanderbilt University
- Icahn School of Medicine at Mount Sinai
- Saskatoon Health Region
- Government of Mexico
- Government of Pakistan
- University of Oxford
- Janssen Pharmaceutica NV
- Max Planck Institute
- Washington University in St. Louis
- South London and Maudsley NHS Foundation Trust
- Northumberland, Tyne and Wear NHS Foundation Trust
- Schulman Research Award
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (15)
- AstraZeneca
- Eli Lilly
- Axsome Therapeutics, Inc.
- University of Pittsburgh
- New York University
- University of Ottawa
- University of Rochester
- University of Toronto
- University of Freiburg
- Department of Veteran Affairs
- Canadian Institutes of Health Research (CIHR)
- Brain & Behavior Research Foundation
- The Physicians' Services Incorporated Foundation
- Johnson and Johnson
- Pakistan Institute of Living and Learning
Organization Involved with Phase 2 Indications (68)
- Takeda
- Millennium Pharmaceuticals
- Roche
- Merck
- Avanir
- Novartis
- CeNeRx BioPharma Inc.
- Evotec
- INC Research
- Relmada Therapeutics, Inc.
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Institutes of Health (NIH)
- National Center for Research Resources (NCRR)
- Brigham and Women's Hospital
- University of Manitoba
- Central South University
- Baylor University
- Brown University
- Emory University
- Temple University
- Johns Hopkins University
- McGill University
- Mclean Hospital
- Radiant Research
- Sheppard Pratt Health System
- Stanford University
- Universidade Federal do Rio Grande do Norte
- University of Heidelberg
- University of Kansas
- University of South Florida
- +38 more
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (7)